Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children. - Wikidata - awgldk - TriplyDB

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

http://www.wikidata.org/entity/Q36770915

about

Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children Immunology of idiopathic nephrotic syndrome.Lessons from genetics: is it time to revise the therapeutic approach to children with steroid-resistant nephrotic syndrome?Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.Idiopathic nephrotic syndrome: the EBV hypothesis.Optimal management of primary focal segmental glomerulosclerosis in adults Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome.The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective.Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome.Minimal Change Disease.Clinical trials in minimal change disease.Glucocorticoids in the Treatment of Glomerular Diseases: Pitfalls and Pearls.Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

P2860

Q26747770-0E3D2011-6087-42A7-B02F-FCBD43C6422A Q38815449-14FD82ED-CF9F-4B3F-BAAA-638B63DA9F64 Q38840895-721ED5E4-62DA-4382-B1C7-9539553F155D Q38895019-22D630EC-ED95-4674-BAFE-7F7BE084A3C9 Q38967341-879DB04A-190E-4A4C-BDF4-70B0F6F6D14F Q39331611-B00E3EF3-64D8-4CD9-A333-3CB093D500DB Q42323598-A24EDDE8-1AA4-472B-8D0A-BC81A3A031ED Q42424215-580DE3EE-8D9E-4301-B15F-65B68D95685C Q50047399-2F065E48-B80D-488F-8FB1-E32EF510AEB4 Q52945061-AA7A3412-664F-4271-914A-90E325DBFACB Q53368686-F9BA7D03-F3D8-4B79-865F-C363B4D9E539 Q53706807-9252E931-D3D2-4282-AF57-5D8C49BFA264 Q55251661-CA6D2C07-0848-4B96-958F-4ACB681488EC

P2860

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

http://www.wikidata.org/entity/Q36770915

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

@ast

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

@en

type

label

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

@ast

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

@en

prefLabel

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

@ast

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

@en

P1433

Q36770915-530D4343-AA6F-4B55-9F19-9B9C96361791

P1476

Q36770915-6D4FB834-B1B3-414E-8157-8EDF5ACD0434

P2093

Q36770915-2C6BFA23-335D-4E29-AEFC-CCC6F2ACE410

Q36770915-93435290-4031-4ED8-8E70-4CE4A138DCC9

Q36770915-B825A299-A1CF-4CF1-B204-F467D03301C7

P2860

Q36770915-021CADC3-6657-412B-94D8-45162E32B460

Q36770915-0532A323-1321-489A-9404-EB4ADD2F643E

Q36770915-17E334F2-91FF-407A-9E57-9F2CCBCF8BF2

Q36770915-18550107-894C-4273-BC36-13B7FA426CC8

Q36770915-2E1E45A8-84A2-400A-9942-D05A43EC97BF

Q36770915-39E15382-BBF9-4A2D-BC90-90BEC5F41FE4

Q36770915-46D8C92E-CA3D-4C1F-81E9-619CA6AE0579

Q36770915-50BCDF0C-5089-43AD-9142-908B1A4ACEFB

Q36770915-5A8952D0-2503-4B97-B7AB-9425C5FA9725

Q36770915-5E72C89E-4AFF-4925-A818-1283B3FCC780

P304

Q36770915-D491AEB2-83B0-49C7-B3DB-50DD1F31396E

P31

Q36770915-6234EC09-CCB4-4BDF-A6C6-0E3E2DE20402

P356

Q36770915-A11D5AD2-8A9C-4431-B3E5-5B372F672750

P433

Q36770915-18DE8391-46B1-468C-A923-120163FA59A1

P478

Q36770915-BFB478CE-576D-4E89-86EA-18021A1DC323

P50

Q36770915-0B0417D5-12AE-431A-87F9-963B0706129E

Q36770915-1DAF8E42-9E31-4DBE-A162-C168590FC455

P577

Q36770915-67AF4662-37FA-4A72-A045-E8ABB4216579

P698

Q36770915-D30B4834-BB67-4C01-A688-58F1D9A7DE0F

P932

Q36770915-FEE9691A-290E-4BE7-BB91-649AF5CFD0A9

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

@en

P2093

Alice Bonanni

http://www.w3.org/2001/XMLSchema#string

Pietro Ravani

http://www.w3.org/2001/XMLSchema#string

Roberta Rossi

http://www.w3.org/2001/XMLSchema#string

P2860

Beyond ecto-nucleotidase: CD39 defines human Th17 cells with CD161

Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy.

Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.

Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes.

Non-infectious pulmonary toxicity of rituximab: a systematic review.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

P304

710-720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.08500815

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Gian Marco Ghiggeri

Gianluca Caridi

P577

2015-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26585985

http://www.w3.org/2001/XMLSchema#string

P932

4822672

http://www.w3.org/2001/XMLSchema#string